(6S)-6-[5-(7-Bromo-9,9-difluoro-9Hfluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester

DRUG INTERMEDIATES

Product Details

CAT No.# CS-O-32126
Category Drug Intermediates
CAS 1441670-89-8
Molecular Weight 541.11
Molecular Formula C27H26BrF2N3O2
Stock Status: In-Stock
Purity: >98%
Synonyms: (6S)-6-[5-(7-Bromo-9,9-difluoro-9Hfluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester;(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester
Application Notes: Ledipasvir Intermediate
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
Related Results for '(6S)-6-[5-(7-Bromo-9,9-difluoro-9Hfluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester'

- API Standards of Ledipasvir
- Stable Isotopes of Ledipasvir
- Metabolites of Ledipasvir
- Impurities of Ledipasvir
- Glucuronides of Ledipasvir
- Intermediates of Ledipasvir

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
7. BISPHENOL AF (RING-13C12)
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline


Smileys:
O=C(N1CC2(CC2)C[C@H]1C3=NC=C(C4=CC=C(C5=CC=C(Br)C=C65)C(C6(F)F)=C4)N3)OC(C)(C)C



This page contains information about (6S)-6-[5-(7-Bromo-9,9-difluoro-9Hfluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester Cas 1441670-89-8 and its Drug Intermediates.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."